Hints and tips:
Related Special Reports
...The private equity group is bidding £700mn ($882mn) for Ergomed, a contract researcher listed on the UK’s junior Aim market....
...The government believes the new funding could unlock a further investment of £70mn from the private sector....
...As a result, the sector is an increasingly popular investment destination for governments, private equity, institutions, venture capital and family offices/private investors....
...Fisher’s private health insurance paid for the drug, but she testified to the UK’s National Institute of Clinical Excellence to try to persuade authorities to pay for it for everyone on the NHS....
...The change is helping the bank to win more private sector work....
...The private equity titan has since increased its holding to 39.9 per cent as Marshall Wace’s assets under management have nearly tripled....
...It caused an estimated $10bn in damages and years of wrangling between companies like pharma group Merck and snack maker Mondelez and their insurers....
...The head of pharma company Sanofi said UK economic policy meant the country was falling behind in healthcare innovation....
...He used to be the chief of French pharma giant Sanofi. Millennium Management, the multi-strategy hedge fund, has hired Justin Gmelich from King Street as its new co-chief investment officer....
...Reliance has recently invested in healthcare companies including genetics group Strand Life Sciences, after buying a majority stake in pharma sales company Netmeds in 2020....
...The Milan-listed drugmaker, which is controlled by private equity CVC Capital Partners through Rossini Investimenti, will buy EUSA Pharma from buyout firm EW Healthcare Partners, it announced on Friday....
...Wednesday: The focus has been on Unilever after its abortive bid for GSK’s consumer unit, but the pharma group has a lot to prove....
...DD’s James Fontanella-Khan reports that $570bn worth of deals have been agreed this year across healthcare, pharma and biotech — 5,316 transactions, to be precise....
...Drugs from rival pharma groups Eli Lilly and Roche may also enter the market earlier than expected....
...(Nikkei Asia via FT) Biden’s blow to Big Pharma Patents are the lifeblood of the pharmaceuticals industry....
...The state-owned pharma group reportedly wants to take China Traditional Chinese Medicine private in a consortium. The parent company plans to offer at least HK$5.10 (US$0.66) per share for China TCM....
...“We are not a pharmaceutical company and this is not a first step to becoming a pharma company,” said Ineos director Tom Crotty....
...Until a dynamite scoop on the internationally reviled “Pharma Bro” provocateur Martin Shkreli sparked into something else — romance....
...The company needs to produce and deliver the jab — a process that has proved fraught for most pharma groups....
...Six other coronavirus vaccine development efforts are being funded by the Coalition for Epidemic Preparedness Innovations, a public-private-charity partnership set up three years ago to develop vaccines...
...Private equity groups Bain Capital and Cinven, which last year joined forces to buy German drugmaker Stada, had also expressed interest in the business....
...The declines of the early listings resulted from “unrealistic” valuations achieved during private funding rounds ahead of the IPOs, said Brad Loncar, who runs exchange traded funds that track US and Chinese...
...BlackRock has been mandated to sell liquid holdings and some illiquid investments, accounting for roughly two-thirds of the £3bn in assets, while PJT will attempt to sell the private and illiquid assets....
...JPMorgan Chase is cutting ties with Purdue Pharma, the OxyContin maker owned by the billionaire Sackler family, because of rising reputational risk....
...There are also many public-private partnerships, including a $250m Dementia Discovery Fund with contributions from the UK government, pharma companies and philanthropists including Bill Gates....
International Edition